Document is current
Any future updates will be listed below
-
Authors
Bianchi, Eleonora
Reddingius, Peter F.
Rathore, Mehal https://orcid.org/0000-0001-5749-2761
Lindfield, Dan
Crabb, David P. https://orcid.org/0000-0001-8754-3902
Jones, Pete R. https://orcid.org/0000-0001-7672-8397
- License Information
-
More Information
Article History
Received: 23 August 2023
Revised: 27 March 2024
Accepted: 11 April 2024
First Online: 27 May 2024
Competing interests
: E Bianchi, None; M Rathore, None; P Reddingius, None; D Lindfield, C: <i>Allergan/Abbvie, Alcon, Sight Sciences, Ellios, Vision Engineering, Glaukos, Santen, Medicom, EndoOptiks, Spectrum, Thea</i><b>;</b> DP Crabb, C: <i>AbbVie/Allergan; Apellis; Janssen;</i> F: <i>AbbVie/Allergan; Apellis; Santen;</i> R: <i>AbbVie/Allergan; Santen; Thea; Glaukos</i>; PR Jones, None; The authors declare no competing interests.
: This study was approved by the NHS Health Research Authority (IRAS ID: #300328).
